Document is current

Any future updates will be listed below

A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer

Crossref DOI link: https://doi.org/10.1007/s00280-014-2563-0

Published Online: 2014-08-21

Published Print: 2014-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark